Sean Gaffney Sells 10,000 Shares of Addus Homecare Co. (NASDAQ:ADUS) Stock

Share on StockTwits

Addus Homecare Co. (NASDAQ:ADUS) EVP Sean Gaffney sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $97.50, for a total value of $975,000.00. Following the transaction, the executive vice president now owns 18,834 shares of the company’s stock, valued at $1,836,315. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of NASDAQ ADUS traded down $0.34 during midday trading on Thursday, hitting $96.37. 1,783 shares of the company’s stock were exchanged, compared to its average volume of 105,929. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.16 and a quick ratio of 3.16. Addus Homecare Co. has a twelve month low of $43.13 and a twelve month high of $106.98. The company has a market cap of $1.51 billion, a PE ratio of 50.10, a P/E/G ratio of 2.45 and a beta of 0.49. The firm’s fifty day simple moving average is $93.02 and its 200-day simple moving average is $86.87.

Addus Homecare (NASDAQ:ADUS) last issued its earnings results on Monday, August 10th. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.29. Addus Homecare had a return on equity of 8.38% and a net margin of 4.24%. The business had revenue of $184.58 million for the quarter, compared to analyst estimates of $172.85 million. Equities analysts anticipate that Addus Homecare Co. will post 2.63 EPS for the current fiscal year.

ADUS has been the subject of a number of research analyst reports. Sidoti raised their target price on Addus Homecare from $96.00 to $115.00 and gave the company a “buy” rating in a report on Monday, June 1st. Zacks Investment Research cut Addus Homecare from a “buy” rating to a “hold” rating in a research note on Monday, August 3rd. Oppenheimer lifted their price objective on Addus Homecare from $107.00 to $115.00 and gave the company an “outperform” rating in a research note on Tuesday, August 11th. BidaskClub cut Addus Homecare from a “hold” rating to a “sell” rating in a research note on Tuesday. Finally, BMO Capital Markets lifted their price objective on Addus Homecare from $103.00 to $115.00 in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the stock. Addus Homecare presently has an average rating of “Buy” and a consensus price target of $104.50.

Several hedge funds and other institutional investors have recently modified their holdings of ADUS. Nisa Investment Advisors LLC acquired a new stake in shares of Addus Homecare during the 2nd quarter worth about $28,000. Marshall Wace North America L.P. acquired a new position in Addus Homecare during the first quarter worth approximately $34,000. Credit Agricole S A acquired a new position in Addus Homecare during the first quarter worth approximately $40,000. Bartlett & Co. LLC acquired a new position in Addus Homecare during the first quarter worth approximately $68,000. Finally, Ladenburg Thalmann Financial Services Inc. increased its position in Addus Homecare by 27.0% during the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 724 shares of the company’s stock worth $70,000 after buying an additional 154 shares during the period. 95.86% of the stock is currently owned by institutional investors and hedge funds.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.

See Also: Fundamental Analysis – How It Helps Investors

Insider Buying and Selling by Quarter for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply